Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
17.56
+0.25 (1.44%)
Sep 18, 2026, 3:04 PM CST
SHE:000623 Market Cap
SHE:000623 has a market cap or net worth of 20.59 billion as of September 18, 2026. Its market cap has decreased by -8.87% in one year.
Market Cap
20.59B
Enterprise Value
20.13B
Revenue
2.24B
Ranking
n/a
PE Ratio
6.51
Stock Price
17.56
ChartMarket Cap Chart
Since April 11, 2006, SHE:000623's market cap has increased from 2.63B to 20.59B, an increase of 683.98%. That is a compound annual growth rate of 10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.59B | -10.09% |
| Dec 31, 2025 | 22.90B | 10.86% |
| Dec 31, 2024 | 20.65B | 20.79% |
| Dec 29, 2023 | 17.10B | 0.46% |
| Dec 30, 2022 | 17.02B | -19.09% |
| Dec 31, 2021 | 21.03B | 10.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.02B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.83B |
| Walvax Biotechnology | 21.29B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Tasly Pharmaceutical Group | 20.71B |
| Livzon Pharmaceutical Group | 20.65B |
| Guangdong Zhongsheng Pharmaceutical | 20.59B |